Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
MagnetOs Granules
Move the needle in fusion with our foundational, proven solution
MagnetOs™ Granules is our original advanced bone graft based on the submicron needle-shaped NeedleGrip™ surface technology. It forms the foundation of all MagnetOs formulations and is the driver of our mechanism of action.
The scientists from Kuros Biosciences have spent more than a decade studying and refining the technology and surface science to harness the power of osteoimmunology.
These continuous efforts to mimic the best features of biologically robust autograft bone have led to the creation of MagnetOs as it is today.
Strong foundation & proven
MagnetOs Granules is the basis for all MagnetOs formulations. This foundational technology has paved the way for more than 25,000 patients treated since 2017 and counting; all supported by an unprecedented blend of scientific, pre-clinical, and clinical studies through our global research program, Project Fusion.1
Harnessing the immune system
MagnetOs is capable of polarizing macrophages from the M1 pro-inflammatory to the M2 pro-healing phenotype, which is known to influence bone growth through secretion of proteins such as BMP-2. MagnetOs stimulates bone growth even in soft tissue, without added cells or growth factors, due to its unique submicron NeedleGrip surface technology.†‡2-4
Equivalent to autograft
In fact, MagnetOs Granules as a standalone bone graft reached higher fusion rates than the gold standard of autograft. This is based on interim results of an observer blinded, randomized, controlled, intrapatient, multi-center clinical trial of instrumented posterolateral fusions, as assessed by fine-cut CT scans at one year follow-up.1
The MagnetOs Granules technology is also proven to be equivalent to autograft for spinal fusions in multiple pre-clinical models.†5,6
Want to learn more about MagnetOs Granules?
Book your own appointment with one of our scientific experts.
Nothing to display.
1. Data on file.
2. Duan, et al. eCM. 2019;37:60-73.
3. Van Dijk, et al. eCM. 2021;41:756-73.
4. Van Dijk, et al. J Immunol Regen Med. 2023;19:100070.
5. Van Dijk, et al. JOR Spine. 2018;e1039.
6. Van Dijk, et al. J Biomed Mater Res. Part B: Appl Biomater. 2019;107(6)2080-2090.
† Results from in vitro or in vivo laboratory testing may not be predictive of clinical experience in humans. For important safety and intended use information please visit kurosbio.com/eifu.
‡ MagnetOs is not cleared by the FDA or TGA as an osteoinductive bone graft.
PROMO/KUR/GL/062-21/R04